{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-151192","form_type":"8-K","ticker":"RIGL","cik":"0001034842","company_name":"RIGEL PHARMACEUTICALS INC","filed_at":"2021-12-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.186584+00:00","generated_at":"2026-06-27T23:58:37.790591+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Rigel Pharmaceuticals appoints Kamil Ali-Jackson to board, expanding board to 10 members","bullets":["Board size increased from 9 to 10; Ali-Jackson appointed effective Dec. 16, 2021, term expires at 2022 annual meeting.","Standard non-employee director compensation: $50k annual retainer, initial option grant for 120,000 shares vesting over 3 years.","Ali-Jackson determined independent under SEC and Nasdaq rules; no transactions requiring disclosure under Item 404(a).","Not appointed to any standing board committee at this time."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-151192","json":"https://secwatch.observer/filing/0001104659-21-151192.json","markdown":"https://secwatch.observer/filing/0001104659-21-151192.md","text":"https://secwatch.observer/filing/0001104659-21-151192.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1034842/000110465921151192/0001104659-21-151192-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1034842/000110465921151192/tm2135755d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T23:58:37.790591+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"be080a7930","claim":"Kamil Ali-Jackson was appointed as Director at RIGEL PHARMACEUTICALS INC.","evidence_excerpt":"On the Effective Date, the Board appointed, upon the recommendation of the Board’s Corporate Governance, Health Care Compliance Oversight and Nominating Committee, Kamil Ali-Jackson to fill in the vacancy on the Board and to serve as a member of the Board until her successor is elected and has qualified, or sooner in the event of her death, resignation or removal.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1034842/000110465921151192/0001104659-21-151192-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}